Chymopapain
From Self-sufficiency
Chymopapain (Brand name: Chymodiactin) is a proteolytic enzyme isolated from the latex of papaya (Carica papaya), it is a medication used to treat slipped (herniated) lower lumbar discs in the spine.[1]. Chymopapain injections should preferably be given under local, rather than general, anaesthesia. The dose for a single intervertebral disc is 2 to 4 nanokatals, with a maximum dose per patient of 8 nanokatals.
The sale and distribution of Chymopapain was discontinued in the United States on January 27, 2003. [2]
Side Effects
Serious side effects from the use of Chymopapain include anaphylaxis, paralysis of the legs, or death. [3]
References
- ↑ Chymopapain Injection from MedicineNet
- ↑ [http://www.mayoclinic.com/health/drug-information/DR600373]
- ↑ [http://www.mayoclinic.com/health/drug-information/DR600373]
Seealso
External Links
- The MEROPS online database for peptidases and their inhibitors: C01.002
- Data sheet for Papain from BIOZYM
 |
This medical article is a stub. You can help ssf by expanding it. |
| This enzyme-related article is a stub. You can help ssf by expanding it. |
